Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 19, 2018
Pharmacy Choice - News - Drug Delivery Systems - August 19, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 100     Next >>     Go To Page:

8/18/18 - 'Pharmaceutical Packaging Market Worth Over $89.5 Billion in 2017' Says Visiongain Report
Visiongain, a independent media company, issued the following news release:. Visiongain's new report Pharmaceutical Packaging Market Report 2017-2027: Global Forecasts by Material, Product Delivery System and Geography indicates that the pharmaceutical packaging market will see over $89.5 bn in revenue in 2017.. The lead analyst of the report said:
8/18/18 - Drug Delivery Systems Market Projected to Reach US$ 900 Bn by 2019
Albany, NY 08/18/2018 Drug Delivery Systems Market: Snapshot. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. For instance, on September 2017, Baxter International Inc. announced the launch of De
8/18/18 - Intravenous Immunoglobulin (IVIG) Market Value to Reach US$14,923.2 Million 2024
Albany, NY 08/18/2018 Global Intravenous Immunoglobulin Market: Analyst's Estimations. In the recent past, IVIG have proven their worth in treating autoimmune diseases such as primary humoral immunodeficiency, multiple sclerosis, immune thrombocytopenia purpura, autoimmune haemolytic anemia, and Kawasaki syndrome. On the basis of indication,
8/18/18 - Neurocrine Biosciences to Present Data on INGREZZA (valbenazine) and Opicapone at the 2018 World Congress on Parkinson`s Disease and Related Disorders [Sport360]
Neurocrine Biosciences, Inc. today announced it will present data from its movement disorders programs, including additional long-term results for INGREZZA capsules, the first U.S. Food and Drug Administration approved treatment for adults with tardive dyskinesia, and data analyses from a Phase III study on opicapone, an investigational treatment f
8/17/18 - 'Infusion Devices Market Set to Grow to $2.9bn by 2022' Says New Visiongain Report
Visiongain' has launched a new pharma report Global Infusion Devices Market Forecast 2018-2028: Syringe, Insulin, Volumetric, Ambulatory, Patient Controlled Analgesia, Implantable, Enteral, Gastroenterology, Diabetes, Analgesia& Pain Management, Chemotherapy, Paediatrics& Neonatology, Hospital, Home Healthcare, Ambulatory Surgical Centres.
8/17/18 - Alnylam Announces Alignment on Value-Based Agreements with Leading Health Insurers and Launches Comprehensive Patient Support Services for ONPATTRO
CAMBRIDGE- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced it has agreed on the structure and key terms of value-based agreements with leading health insurers for ONPATTRO lipid complex injection, a first-of-its-kind RNA interference therapeutic for the treatment of the polyneuropathy of hereditary...
8/17/18 - Alnylam Announces First-Ever FDA Approval of an RNAi Therapeutic, ONPATTRO for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
CAMBRIDGE- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the United States Food and Drug Administration approved ONPATTRO lipid complex injection, a first-of-its-kind RNA interference therapeutic, for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
8/17/18 - Amicus Therapeutics - FDA Approves Galafold for the Treatment of Certain Adult Patients with Fabry Disease
CRANBURY- Amicus Therapeutics today announced that the U.S. Food and Drug Administration has granted accelerated approval of Galafold 123 mg capsules. As a condition of accelerated approval, Amicus Therapeutics will continue to study Galafold in a confirmatory Phase 4 program. John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeu
8/17/18 - Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector
Antares Pharma announced that the U.S. Food and Drug Administration has approved Teva Pharmaceutical, epinephrine auto injector drug-device combination product indicated for emergency treatment of severe allergic reactions including those that are life threatening in adults and certain pediatric patients. We are extremely pleased with the FDA
8/17/18 - Dual Chamber Prefilled Syringes Market : Glass to Remain Preferred Product Material for Dual Chamber Prefilled Syringes: Glass will remain preferred product material for dual chamber prefilled syringes, mainly because of its non-reactive nature, and
Rockville, WA 08/17/2018 According to Fact.MR' s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period. Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026- end. Dual Chamber Prefi
8/17/18 - FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease
The U.S. Food and Drug Administration today approved Onpattro infusion for the treatment of peripheral nerve disease caused by hereditary transthyretin-mediated amyloidosis in adult patients. This is the first FDA- approved treatment for patients with polyneuropathy caused by hATTR, a rare, debilitating and often fatal genetic disease characterized
8/17/18 - Global Oral Thin Films Market to Reach over US$ 6,000.0 Mn by 2025 : Latest Technology Advancements to Drive Market
Albany, NY 08/16/2018 This report analyzes the current and future scenario of the global oral thin films market. Rise in demand for thin film drug delivery systems, considerable research and development in the segment, low development cost as compared to new drugs, and strategic alliances between novel technology owners and pharmaceutical gia
8/17/18 - Investigators from Kansai University Release New Data on Drug Delivery Systems [Preparation of Biodegradable Oligo(lactide)s-Grafted Dextran Nanogels...
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting from Osaka, Japan, by NewsRx journalists, research stated, "Nanogels, nanometer-sized hydrogel particles, have great potential as drug delivery carriers. The news correspondents obtained a q
8/17/18 - Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Progress in Revolutionary Alternative to Smoking for Drug Delivery
Smoking-related deaths have reached six million a year worldwide Lexaria's patented drug delivery platform aims to deliver commonly smoked drugs in a non-smoking form factor that sidesteps smoking's hazards Second round of testing continues to indicate that patented DehydraTECH? platform provides rapid delivery with high bioavailability As wo
8/17/18 - Needle Free Drug Delivery Device Market Trends by 2025: Top Players Like Bespak, Zogenix, InsuJet, 3M, Crossject, Valeritas, INJEX: The Needle Free Drug Delivery Device market report defines all important industrial or business terminologies. Industr
New York, NY 08/17/2018 Top key vendors in Needle Free Drug Delivery Device Market include are 3 M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, INJEX, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, Zogenix, Advantajet, InsuJet, Antares Pharma, D'Antonio Consultant
8/17/18 - New Drug Delivery Systems Findings Reported from Chinese Academy of Sciences (Stable pyrazolate-based metal-organic frameworks for drug delivery)
According to news originating from Fujian, People's Republic of China, by NewsRx correspondents, research stated, "To explore materials stable in alkaline solution, a linear ligands 1,4- benzenedi, in which the pyrazolate group was considered as a soft Lewis base, was used to reacted with two relative soft Lewis acid Ni and Zn metal ions, to constr
8/17/18 - New Drug Delivery Systems Study Findings Recently Were Reported by Researchers at Sapienza-University (Effect of glycerol on the physical and...
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting out of Rome, Italy, by NewsRx editors, research stated, "In this work, deacylated gellan gum and the plasticizer glycerol were used as primary components for the preparation of thin films in
8/17/18 - New Findings Reported from Tohoku University Describe Advances in Retinal Diseases and Conditions (Drug delivery devices for retinal diseases)
According to news reporting originating in Miyagi, Japan, by NewsRx journalists, research stated, "Retinal degenerative diseases are a leading cause of irreversible blindness and visual impairment, affecting millions of people worldwide. The news reporters obtained a quote from the research from Tohoku University, "The design of drug delivery syste
8/17/18 - Ocular Drug Delivery Technology Market : Affordability of Topical Technology Drives Their Sales
The three leading firms in the market are Valeant Pharmaceuticals International, Inc., Alimera Sciences, and Santen Pharmaceutical Co., Ltd. These firms held more than 50% of the overall share of the market. Among them, Santen Pharmaceuticals and Valeant Pharmaceuticals dominates the market due to its wide range of ocular drugs it manufactures in t
8/17/18 - Prefilled Syringes Market Will Reach at a CAGR of 9.6% from 2017 to 2026: Fact.MR has announced the addition of the Prefilled Syringes Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2026.
Rockville, MD 08/17/2018 With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. For instance, Becton Dickinson has developed PosiFlush prefilled syringes with a 4% sodium citrate lock solution that can reduce the number of cathete
8/17/18 - Recent Findings in Drug Delivery Systems Described by Researchers from University of Sheffield (Catalytic Janus Colloids: Controlling Trajectories of...
Recent Findings in Drug Delivery Systems Described by Researchers from University of Sheffield. According to news reporting originating from Sheffield, United Kingdom, by NewsRx correspondents, research stated, "Catalytic Janus colloids produce rapid motion in fluids by decomposing dissolved fuel. Our news editors obtained a quote from the research
8/17/18 - Red-blood-cell 'hitchhikers' offer new way to transport drugs to specific targets
By a News Reporter-Staff News Editor at Drug Week PHILADELPHIA- A new drug-delivery technology which uses red blood cells to shuttle nano-scale drug carriers, called RBC-hitchhiking, has been found in animal models to dramatically increase the concentration of drugs ferried precisely to selected organs, according to a study published in Nature...
8/17/18 - Reports on Drug Delivery Systems Findings from University of Shanghai for Science & Technology Provide New Insights (Fast dissolving drug...
Reports on Drug Delivery Systems Findings from University of Shanghai for Science& Technology Provide New Insights. According to news reporting originating from Shanghai, People's Republic of China, by NewsRx correspondents, research stated, "Structural nanocomposites that provide fast dissolving drug release profiles are highly in demand in...
8/17/18 - Reports Outline Cystic Fibrosis Findings from Institute of Pharmacy [Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin...
Reports Outline Cystic Fibrosis Findings from Institute of Pharmacy. According to news originating from Innsbruck, Austria, by NewsRx correspondents, research stated, "The aim of this study was to develop a self-emulsifying drug delivery system containing the fluoroquinolone antibiotic ciprofloxacin exhibiting highly mucus permeating properties and
8/17/18 - Reports Summarize Drug Delivery Systems Study Results from University of Ege (Enhancing Solubility and Bioavailability of Rosuvastatin into Self...
Reports Summarize Drug Delivery Systems Study Results from University of Ege. According to news reporting from Izmir, Turkey, by NewsRx journalists, research stated, "The aim of this study was to develop new Rosuvastatin calcium self nanoemulsifying drug delivery system and to evaluate the bioavailability and pharmacodynamic effect of RCa-SNEDDS in
Articles(s): 1 - 25 of 100     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415